Azelis Group NV [AZE] vs Solvay SA [SOLB] Detailed Stock Comparison
Azelis Group NV
Euronext
Loading...
Solvay SA
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Azelis Group NV wins in 6 metrics, Solvay SA wins in 13 metrics, with 0 ties. Solvay SA appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Azelis Group NV | Solvay SA | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 19.29 | 21.42 | Azelis Group NV |
| Price-to-Book Ratio | 1.22 | 2.57 | Azelis Group NV |
| Debt-to-Equity Ratio | 77.22 | 185.12 | Azelis Group NV |
| PEG Ratio | 11.57 | 6.89 | Solvay SA |
| EV/EBITDA | 10.97 | 6.74 | Solvay SA |
| Profit Margin (TTM) | 4.01% | 2.81% | Azelis Group NV |
| Operating Margin (TTM) | 8.89% | 10.40% | Solvay SA |
| EBITDA Margin (TTM) | 8.89% | 10.40% | Solvay SA |
| Return on Equity | 6.41% | 11.13% | Solvay SA |
| Return on Assets (TTM) | 3.98% | 4.73% | Solvay SA |
| Free Cash Flow (TTM) | $309.06M | $330.00M | Solvay SA |
| Dividend Yield | 3.25% | 8.39% | Solvay SA |
| 1-Year Return | -21.45% | -8.66% | Solvay SA |
| Price-to-Sales Ratio (TTM) | 0.77 | 0.59 | Solvay SA |
| Enterprise Value | $4.89B | $4.88B | Azelis Group NV |
| EV/Revenue Ratio | 1.16 | 0.99 | Solvay SA |
| Gross Profit Margin (TTM) | N/A | 20.79% | N/A |
| Revenue per Share (TTM) | $17 | $47 | Solvay SA |
| Earnings per Share (Diluted) | $0.69 | $1.31 | Solvay SA |
| Beta (Stock Volatility) | 0.57 | 0.69 | Azelis Group NV |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Azelis Group NV vs Solvay SA Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Azelis Group NV | 1.27% | 2.57% | 0.15% | -2.02% | -31.43% | -29.72% |
| Solvay SA | 1.35% | 3.49% | -3.66% | -7.05% | -5.98% | -8.07% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Azelis Group NV | -21.45% | -42.68% | -51.61% | -51.61% | -51.61% | -51.61% |
| Solvay SA | -8.66% | -67.35% | -61.28% | -73.78% | -65.66% | -65.66% |
Performance & Financial Health Analysis: Azelis Group NV vs Solvay SA
| Metric | AZE | SOLB |
|---|---|---|
| Market Information | ||
| Market Cap | €3.24B | €2.93B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 339,305 | 301,565 |
| 90 Day Avg. Volume | 287,612 | 259,236 |
| Last Close | €13.55 | €28.46 |
| 52 Week Range | €12.82 - €21.00 | €27.24 - €39.37 |
| % from 52W High | -35.48% | -27.71% |
| All-Time High | €29.90 (Sep 13, 2021) | €132.61 (Apr 06, 2015) |
| % from All-Time High | -54.68% | -78.54% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | -0.09% |
| Quarterly Earnings Growth | -0.12% | -0.87% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 0.03% |
| Operating Margin (TTM) | 0.09% | 0.10% |
| Return on Equity (TTM) | 0.06% | 0.11% |
| Debt to Equity (MRQ) | 77.22 | 185.12 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €10.90 | €10.91 |
| Cash per Share (MRQ) | €1.86 | €3.30 |
| Operating Cash Flow (TTM) | €323.63M | €551.00M |
| Levered Free Cash Flow (TTM) | €33.84M | €132.50M |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.25% | 8.39% |
| Last 12-Month Dividend | €0.45 | €2.43 |
Valuation & Enterprise Metrics Analysis: Azelis Group NV vs Solvay SA
| Metric | AZE | SOLB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 19.29 | 21.42 |
| Forward P/E | 11.57 | 6.89 |
| PEG Ratio | 11.57 | 6.89 |
| Price to Sales (TTM) | 0.77 | 0.59 |
| Price to Book (MRQ) | 1.22 | 2.57 |
| Market Capitalization | ||
| Market Capitalization | €3.24B | €2.93B |
| Enterprise Value | €4.89B | €4.88B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.16 | 0.99 |
| Enterprise to EBITDA | 10.97 | 6.74 |
| Risk & Other Metrics | ||
| Beta | 0.57 | 0.69 |
| Book Value per Share (MRQ) | €10.90 | €10.91 |
Financial Statements Comparison: Azelis Group NV vs Solvay SA
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AZE | SOLB |
|---|---|---|
| Revenue/Sales | N/A | €1.24B |
| Cost of Goods Sold | N/A | €991.00M |
| Gross Profit | N/A | €252.00M |
| Research & Development | N/A | €-4.00M |
| Operating Income (EBIT) | N/A | €147.00M |
| EBITDA | N/A | €244.00M |
| Pre-Tax Income | N/A | €115.00M |
| Income Tax | N/A | €32.00M |
| Net Income (Profit) | N/A | €83.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AZE | SOLB |
|---|---|---|
| Cash & Equivalents | €303.95M | €451.00M |
| Total Current Assets | €1.58B | €2.37B |
| Total Current Liabilities | €818.87M | €1.71B |
| Long-Term Debt | €1.75B | €2.09B |
| Total Shareholders Equity | €2.92B | €1.43B |
| Retained Earnings | €876.33M | N/A |
| Property, Plant & Equipment | €103.92M | €2.46B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AZE | SOLB |
|---|---|---|
| Operating Cash Flow | N/A | €113.00M |
| Capital Expenditures | N/A | €-46.00M |
| Free Cash Flow | N/A | €64.00M |
| Debt Repayment | N/A | €-22.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AZE | SOLB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 339,305 | 301,565 |
| Average Daily Volume (90 Day) | 287,612 | 259,236 |
| Shares Outstanding | 243.51M | 104.47M |
| Float Shares | 175.39M | 65.46M |
| % Held by Insiders | 0.00% | 0.31% |
| % Held by Institutions | 0.79% | 0.27% |
Dividend Analysis & Yield Comparison: Azelis Group NV vs Solvay SA
| Metric | AZE | SOLB |
|---|---|---|
| Last 12-Month Dividend | €0.45 | €2.43 |
| Last 12-Month Dividend Yield | 3.25% | 8.39% |
| 3-Year Avg Annual Dividend | €0.24 | €3.81 |
| 3-Year Avg Dividend Yield | 1.44% | 3.44% |
| 3-Year Total Dividends | €0.73 | €11.42 |
| Ex-Dividend Date | Jun 27, 2025 | May 19, 2025 |